Authors


Jose C. Menezes

Latest:

Using Industry 4.0 to Optimize Oral Solid Dosage Form Manufacturing

Real-time monitoring and the principles of quality by design were used to optimize an OSD coating process.


Jarkko Rautio

Latest:

Enhanced brain drug delivery and targeting

The blood–brain barrier (BBB) forms an interface between the circulating blood and the brain, and functions as a tremendously effective barrier for the delivery of potential neurotherapeutics into the brain parenchyma. Conversely, the BBB possesses various carrier-mediated transport systems for the uptake of small molecules, such as essential nutrients and vitamins. These transporters have become an attractive target for drug/prodrug design in an attempt to ferry drug molecules across the BBB. Central nervous system (CNS) drug delivery is often limited by poor brain penetration of the potential drug candidate. As a result of its unique barrier properties, the BBB poses a huge challenge for the delivery of potential neurotherapeutics into the brain parenchyma.1 It is estimated that only 2% of small-molecule drugs and ,0.1% of novel protein and peptide pharmaceuticals developed for CNS diseases reach therapeutic concentrations in the brain.2,3 Many of the pharmacologically active drugs tend to fail..


Ali R. Rajabi-Siahboomi

Latest:

The influence of concomitant use of alcoholic beverages on hypromellose matrix tablets

Research shows that both drug prescription and alcohol consumption increase within the elderly population. It is, therefore, necessary to fully understand the impact of alcohol consumption on solid oral dosage forms, especially extended release formulations.


David W. Osborne

Latest:

Formulating Topical Products Containing Live Microorganisms as the Active Ingredient

Case studies compare efficacy testing of preservatives for topical formulations with probiotic actives.


Christopher D. Brown

Latest:

Verification Methods for 198 Common Raw Materials Using a Handheld Raman Spectrometer

Using handheld Raman spectroscopy, methods were developed and evaluated for 198 substances widely used as raw materials.


Guillaume Doane

Latest:

EC Reviews: An Executive Country Review on Turkey

In the wake of economic growth, healthcare reforms, and large-scale industry investment, Turkish pharmaceutical companies are charting their own destiny.


Howard Silver

Latest:

Compliance in an Outsource Manufacturing Model: What to Look For

The authors provide detailed lists of important checkpoints to consider when selecting an outsourcing provider.


Doug Dunn

Latest:

Formulation effects on the thermomechanical properties and permeability of free films and coating films

Understanding a formulation's variable effects on its properties, especially film permeability, is key to designing a robust formulation and reducing variation of a finished product.


Mahesh Phansalkar

Latest:

Process Considerations During API Development

This article looks at how to adopt a systematic and prospective approach in the API development process to achieve documented, controlled synthetic processes...


Brian K. Meyer

Latest:

Establishing Material Compatibility, Process Conditions, and Bubble Points of Filters

The authors explain the factors that can cause a failure in a bubble-point integrity test and what to consider when a product-specific bubble point must be defined.


Stefan Schneid

Latest:

Peer-Reviewed Technical Note: Quality by Design in Freeze-Drying

Cycle design and robustness testing using advanced process analytical technology.


M. Serpil Kislalioglu, PhD

Latest:

Effect of Formulation and Process Variables on Matrix Erosion and Drug Release from a Multiunit Erosion Matrix of a Poorly Soluble Drug

By optimizing formulation and process varibles, pellets can be prepared that can release a poorly soluble drug for 12-24 h following zero-order kinetics.


Mary Ann Smith

Latest:

Quality by Design for analytical methods for use with orally inhaled and nasal drug products

The design of accurate and robust analytical methodology is instrumental to developing orally inhaled and nasal drug products (OINDPs) and their appropriate control programmes.


Thomas P. Farrell

Latest:

Narrowing the gap between clinical capsule formulations and commercial film-coated tablets

Based on formulation simplicity and blinding capability, hard gelatin capsules are preferrable compared with other oral solid dosage forms, including tablets, in the early clinical phases of drug development.


Scott W. Sommer

Latest:

A Case for Developing a Standards-Based Approach to Plug-and-Play Equipment

Industry needs a standard to connect systems and equipment sooner rather than later.


Arthur J. Falk, PhD

Latest:

Inside IPEC: Excipient Pedigree as a Supply Chain Tool

It's time to maintain a thorough traceable excipient trail.


Hemant N. Joshi, PhD, MBA

Latest:

Analysis of the Indian Pharmaceutical Industry

India's pharmaceutical industry, which is one of the country's major economic sectors, is poised to make signficant gains on the global market.


Rong Yi

Latest:

LC–MS/MS method for the determination of Vitamin D3 in human plasma

An LC–MS/MS method for the quantitative determination of vitamin D3 in human plasma has been developed and validated with positive atmospheric chemical ionization sources.


Grace van der Gugten

Latest:

LC–MS/MS method for the determination of Vitamin D3 in human plasma

An LC–MS/MS method for the quantitative determination of vitamin D3 in human plasma has been developed and validated with positive atmospheric chemical ionization sources.


Pradeep Karatgi

Latest:

Orally disintegrating tablets: the path to improved patient compliance and enhanced life cycle management

Orally disintegrating tablets offer numerous advantages compared with traditional tablets and capsules, and can be an effective solution for developing line extensions of currently marketed therapies.


Osama Abu Diak

Latest:

Hot-melt extrusion: an emerging drug delivery technology

Hot-melt extrusion offers many advantages compared with conventional solid dosage form manufacturing, and has consequently received considerable attention from both the pharmaceutical industry and academia as a novel drug delivery technology. The possibility of forming solid dispersions with improved bioavailability renders hot-melt extrusion an excellent alternative to other conventionally employed techniques.



Anita Y. Szajek

Latest:

Control Strategies for Synthetic Therapeutic Peptide APIs Part III: Manufacturing Process Considerations

USP's Therapeutic Peptides Expert Panel discusses manufacturing processes and impurity control for synthetic peptide APIs.


Fabien Roy

Latest:

Joining the parallel lines

...some companies complained that what they received was not joint advice or combined advice but parallel advice, without coherence...


Bodo Fritzsching

Latest:

Fast dissolving disintegrating tablets with isomalt

During the past years, there has been increasing demand for fast dissolving disintegrating tablets (FDDTs), such as orally disintegrating tablets (ODTs) and sublinguals.


Henk te Wierik

Latest:

Formulation of Lactose for Inhaled Delivery Systems

Dry powder inhalers (DPIs) contain a powder which, when required, is discharged and inhaled. The therapeutic drug is manufactured in powder form as small particles a few micrometres in diameter. In many DPIs, the drug is mixed with much larger sugar crystals, such as lactose, and the smaller drug particles attach to these excipient particles, improving entrainment of the drug upon inhalation. This article examines how the application and combination of versatile processes such as milling, micronizing, sieving and air classification can be used to manufacture dedicated lactose products for practically every possible combination of active and excipient blend in DPIs.


Jonas Berggren

Latest:

Better, wetter: an alternative approach to calcium carbonate granulation

New research suggests calcium carbonate tablets are stronger and less porous when manufactured using a wet, rather than a dry, granulation process.


Paul Gardiner

Latest:

Organizational polygamy

Paul Gardiner and Andrea Sobrio explain why most companies need 'organizational polygamy' to maximize profit and best serve their customers.


Shimadzu Scientific Instruments Inc.

Latest:

Dual Injection (U)HPLC for Analysis of Pharmaceuticals

This application demonstrates the efficiency, throughput, and reliability of a dual injection system for finished pharmaceutical products and in-process APIs.


Peter Lambert

Latest:

Dispensing Biopharmaceuticals with Piston and Peristaltic Pumps

Piston pumps have been a traditional liquid-filling technology for biopharmaceutical manufacturers, but new challenges, stricter validation requirements, and design innovations have led manufacturers to consider peristaltic filling technology.